CD30 expression in peripheral T-cell lymphomas

Haematologica

Volumn 98, Issue 8, 2013, Pages

  Sabattini, Elena ^a   Pizzi, Marco ^b   Tabanelli, Valentina ^a   Baldin, Pamela ^a   Sagramoso Sacchetti, Carlo ^a   Agostinelli, Claudio ^a   Luigi Zinzani, Pier ^a   Pileri, Stefano A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angioimmunoblastic T cell lymphoma; Enteropathy associated T cell lymphoma; Extranodal NK T cell lymphoma; Nasal type

Indexed keywords

BRENTUXIMAB VEDOTIN; CD30 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR PAX5;

CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CELL GROWTH; CELL SURVIVAL; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LETTER; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; NK T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY;

EID: 84880977905     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.084913     Document Type: Letter

References (15)

1. Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol. 1999;90(2):157-64.
2. Buchan SL, Al-Shamkhani A. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-tB signaling. PLoS One. 2012; 7(9):e45244.
3. Werner B, Massone C, Kerl H, Cerroni L. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. J Cutan Pathol. 2008;35(12):1100-7.
4. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66(4):848-58.
5. Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, et al. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet. 1992;339(8803):1195-6.
6. Tazzari PL, de Totero D, Bolognesi A, Testoni N, Pileri S, Roncella S, et al. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. Haematologica. 1999;84(11):988-95.
7. Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med. 2010;363(19):1812-21.
8. Gibb A, Jones C, Bloor A, Kulkarni S, Illidge T, Linton K, et al. Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK Centre. Haematologica. 2012;98:(4)611-4.
9. Duvic M. CD30+ neoplasms of the skin. Curr Hematol Malig Rep. 2011;6(4):245-50.
10. Cheson BD, Horwitz SM, Weisenburger DD. Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, Hawaii. Clin Adv Hematol Oncol. 2011;9(11 Suppl 26):1-14.
11. Pongpruttipan T, Sukpanichnant S, Assanasen T, Wannakrairot P, Boonsakan P, Kanoksil W, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and nn, and, T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36(4):481-99.
12. Nikoo A. The expression of CXCR3 and CD30 in mycosis fungoides. Arch Iran Med. 2012;15(3):146-50.
13. Benner MF, Jansen PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood 2012;119(7):1643-9.
14. Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006; 24(16):2472-9.
15. Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, et al. Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol. 1997;183(1):116-23.